BACK

MKT CAP:$212715

IMAC Holdings, Inc.

Market Cap

$212715

Healthcare·Medical - Care Facilities·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.06-$0.07 (-51.59%)

Apr 22, 2026

Company Details

IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasiv...

CEO

Faith Zaslavsky

IPO Date

Feb 13, 2019

Website

www.imacholdings.com

Key Metrics TTM

Revenue

$77.5K

+103.7% YoY

Net Income

-$10M

EPS (Diluted)

-$6.82

Free Cash Flow

-$5M

Revenue / Share

$0.02

Gross Margin

-492.7%

Operating Margin

-9853.0%

Net Margin

-12520.1%

FCF Margin

-6306.1%

P/S

2.7x

P/E

—

Earnings Reports

Q3 2025

Dec 17, 2025

$21.2K-62.3%EPS -$1.15

Q2 2025

Aug 14, 2025

$0-100.0%EPS -$0.89

Q4 2024

Apr 14, 2025

$0+100.0%EPS -$3.22

Q3 2024

Jan 17, 2025

$56.3K-96.4%EPS -$1.56

Q2 2024

Dec 18, 2024

$15.8K-98.8%EPS -$1.17

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 19	$4M	$3M	-$2M
Q4 19	$4M	$4M	-$1M
Q1 20	$3M	$3M	-$2M
Q2 20	$3M	$2M	-$2M
Q3 20	$3M	$3M	-$1M
Q4 20	$3M	$3M	-$1M
Q1 21	$3M	$3M	-$2M
Q1 23	$2M	$2M	-$1M
Q2 23	$1M	$1M	-$1M
Q3 23	$2M	$653.6K	-$707.5K
Q4 23	-$5M	$199.6K	$442.9K
Q2 24	$15.8K	-$56.3K	-$1M
Q3 24	$56.3K	-$65.8K	-$2M
Q4 24	$0	-$111.2K	-$2M
Q2 25	$0	-$102.3K	-$2M
Q3 25	$21.2K	-$102.7K	-$2M

Valuation

Quarter	P/S	P/E
Q3 19	2.4x	—
Q4 19	0.9x	—
Q1 20	1.1x	—
Q2 20	1.0x	—
Q3 20	0.7x	—
Q4 20	1.3x	—
Q1 21	1.7x	—
Q1 23	0.4x	—
Q2 23	0.5x	—
Q3 23	0.3x	—
Q4 23	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q2 25	1.1x	—
Q3 25	3.5x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 20	-$1M	-$1M
Q4 20	-$2M	-$2M
Q1 21	-$2M	-$2M
Q2 21	-$3M	-$3M
Q3 21	-$1M	-$2M
Q3 22	-$2M	-$2M
Q1 23	-$1M	-$1M
Q2 23	-$252.7K	-$252.7K
Q3 23	-$1M	-$1M
Q4 23	$167.0K	$167.0K
Q2 24	-$727.9K	-$727.9K
Q3 24	-$1M	-$1M
Q4 24	-$1M	-$1M
Q1 25	-$1M	-$1M
Q2 25	-$1M	-$1M
Q3 25	-$1M	-$1M

Capital Expenditures

Quarter	CapEx
Q3 20	$42.1K
Q4 20	$73.4K
Q1 21	$65.8K
Q2 21	$175.2K
Q3 21	$130.9K
Q3 22	$29.7K
Q1 23	$0
Q2 23	$4
Q3 23	$0
Q4 23	$0
Q2 24	$0
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 19	+586.3%	+286.0%
Q4 19	+68.0%	+42.7%
Q1 20	+1.5%	+29.3%
Q2 20	-7.1%	+4.1%
Q3 20	-20.2%	-20.2%
Q4 20	-18.4%	-7.7%
Q1 21	-7.7%	-3.8%
Q1 23	-18.6%	-20.8%
Q2 23	-61.4%	-43.1%
Q3 23	-54.8%	-53.8%
Q4 23	-263.3%	-206.5%
Q2 24	-99.2%	-58.2%
Q3 24	-95.8%	-24.7%
Q4 24	-100.0%	-20.1%
Q2 25	+100.0%	+136.2%
Q3 25	+34.7%	+32.2%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 20	$0	0.0%
Q4 20	$0	0.0%
Q1 21	$0	0.0%
Q2 21	$0	—
Q3 21	$0	—
Q3 22	$0	—
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	—
Q2 24	$0	0.0%
Q3 24	$3.6K	6.3%
Q4 24	$31.9K	—
Q1 25	$0	—
Q2 25	$0	—
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	S&M
Q3 19	$4M	$317.8K
Q4 19	$4M	$224.2K
Q1 20	$4M	$241.8K
Q2 20	$4M	$174.3K
Q3 20	$4M	$234.7K
Q4 20	$4M	$282.5K
Q1 21	$4M	$265.5K
Q1 23	$1M	$7.7K
Q2 23	$2M	$36.8K
Q3 23	$1M	$8.7K
Q2 24	$1M	—
Q3 24	$2M	—
Q4 24	$2M	—
Q2 25	$2M	—
Q3 25	$2M	—

Revenue Segments

Quarter	Patient Revenues	Operating Segments
Q1 21	$3M	—
Q2 25	—	$102.3K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 20	$1M	$0	$1M
Q3 20	$2M	$0	$2M
Q4 20	$3M	$0	$3M
Q3 22	$3M	$0	$3M
Q4 22	$763.2K	$0	$763.2K
Q1 23	$390.1K	$0	$390.1K
Q2 23	$247.0K	$0	$247.0K
Q3 23	$224.6K	$0	$224.6K
Q4 23	$221.5K	$0	$221.5K
Q1 24	$17.5K	$0	$17.5K
Q2 24	$890.6K	$0	$890.6K
Q3 24	$195.5K	$0	$195.5K
Q4 24	$504.2K	$0	$504.2K
Q1 25	$30.9K	$0	$30.9K
Q2 25	$42.7K	$0	$42.7K
Q3 25	$45.1K	$0	$45.1K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 19	279K	+41.3%	+15.5%
Q4 19	287K	+2.7%	+18.7%
Q1 20	320K	+11.8%	+32.7%
Q2 20	339K	+6.0%	+72.0%
Q3 20	395K	+16.3%	+41.5%
Q4 20	418K	+6.0%	+46.0%
Q1 21	448K	+7.2%	+39.9%
Q1 23	1M	+145.5%	+224.2%
Q2 23	1M	+0.4%	+179.9%
Q3 23	1M	+0.2%	+164.6%
Q4 23	911K	-17.8%	+103.1%
Q2 24	1M	+29.7%	+7.4%
Q3 24	1M	+19.8%	+28.1%
Q4 24	2M	+10.9%	+41.8%
Q2 25	4M	+141.1%	+315.7%
Q3 25	4M	0.0%	+220.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 19	—	—
Q4 19	—	—
Q1 20	—	—
Q2 20	—	—
Q3 20	—	—
Q4 20	—	—
Q1 21	—	—
Q1 23	$24.6K	85
Q2 23	$15.8K	85
Q3 23	$18.4K	85
Q4 23	-$3M	2
Q2 24	$7.9K	2
Q3 24	$28.1K	2
Q4 24	$0	15
Q2 25	$0	15
Q3 25	$1.4K	15

Revenue / Employee